Raising the immunization rate in medical students against measles, mumps and rubella at the University of Berne;Die erhohung der immunitatsrate von medizinstudentinnen und -studenten gegen masern, mumps und roteln an der Universitat Bern

Schweizerische Medizinische Wochenschrift

Volumn 129, Issue 13, 1999, Pages 499-507

  Germann, D ^a,b   Matter, L ^a  

^a UNIVERSITY OF BERN   (Switzerland)

^b CANTONAL HOSPITAL ST GALLEN   (Switzerland)

Author keywords

Measles; Medical students; Mumps; Rubella; Vaccination

Indexed keywords

MEASLES MUMPS RUBELLA VACCINE;

ANTIBODY TITER; ARTICLE; FEMALE; HUMAN; IMMUNIZATION; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MEASLES; MEDICAL STUDENT; MUMPS; RUBELLA; SEROPREVALENCE; VACCINATION; VIRUS INFECTION; ADULT; METHODOLOGY; PREVENTIVE HEALTH SERVICE; SWITZERLAND;

ADULT; FEMALE; HUMANS; IMMUNIZATION PROGRAMS; MALE; MASS SCREENING; MEASLES; MUMPS; RUBELLA; STUDENTS, MEDICAL; SWITZERLAND;

EID: 0033518934     PISSN: 00367672     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (28)

1. Bundesamt für Gesundheit, Schweizerische Kommission für Impffragen. Richtlinien zur Bekämpfung übertragbarer Krankheiten: Impfplan für routinemässige Schutzimpfungen. In: Schorr D, Hrsg. Infektionskrankheiten: Diagnose und Bekämpfung. Bern: Bundesamt für Gesundheit, 1998; Kapitel 1 (Suppl VIII):1-4.
2. Just M. Der neue Schweizerische Impfplan. Ther Umschau 1986;43:565-71.
3. Peltola H, Heinonen OP, Valle M, Paunio M, Virtanen M, Karanko V, et al. The elimination of indigenous measles, mumps, and rubella from Finland by a 12-year, two-dose vaccination program. N Engl J Med 1994;331:1397-402.
4. Nokes DJ, Anderson RM. The use of mathematical models in the epidemiological study of infectious diseases and the design of mass immunization programmes. Epidemiol Infect 1988;101:1-20.
5. Bundesamt für Gesundheit. Masern, Mumps-, Röteln-Durchimpfung bei Schulkindern in der Schweiz 1987-1990. Bull BAG 1991;19:278-83.
6. Matter L, Germann D, Bally F, Schopfer K. Age-stratified seroprevalence of measles, mumps and rubella (MMR) virus infections in Switzerland after the introduction of MMR mass vaccination. Eur J Epidemiol 1997;13:61-6.
7. Zäch K, Nicoara C, Germann D, Matter L. Altersabhängige Seroprävalenz von Masern-, Mumps- und Rötelnantikörpern im Jahr 1996. Schweiz Med Wochenschr 1998;128: 649-57.
8. Maurer AM, Seiler AJ. Durchimpfung bei Kleinkindern und Schulkindern im Kanton Bern. Soz Präventivmed 1997;42: 324-31.
9. Matter HC, Cloëtta J, Zimmermann H. Measles, mumps and rubella: monitoring in Switzerland through a sentinel network, 1986-94. J Epidemiol Commun Health 1995;49:4-8.
10. Germann D, Ströhle A, Eggenberger K, Steiner CA, Matter L. An outbreak of mumps in a population partially vaccinated with the Rubini strain. Scand J Infect Dis 1996;28:235-8.
11. Pfiffner D, Sentinella-Arbeitsgemeinschaft. Verstärkte Masernaktivität in der Schweiz. Bull BAG 1997;33:11-2.
12. Bundesamt für Gesundheit. Schweizerisches Sentinella-System. Zehn Jahre Monitoring durch Impfung verhütbarer Krankheiten. Bull BAG 1997;38:8-10.
13. Maurer AM, Mühlemann K. Masern-Ausbrüche im Kanton Bern. Schweiz Med Wochenschr 1998;128:317-22.
14. Istre GR, McKee PA, Wets GR, O'Mara DJ, Rettig PJ, Stuemky J, et al. Measles spread in medical settings: an important focus of disease transmission? Pediatrics 1987;79: 356-8.
15. Sienko DG, Friedman C, McGee HB, Allen MJ, Simonsen WF, Wentworth BB, et al. A measles outbreak at university medical settings involving health care providers. Am J Public Health 1987;77:1222-4.
16. Poland GA, Nichol, KL. Medical students as sources of rubella and measles outbreaks. Arch Intern Med 1990; 150:44-6.
17. Editorial. Vaccine-preventable diseases and medical personnel: ensure the immunity of all! Arch Intern Med 1990; 150:25-6.
18. Atkinson WL, Markowitz LE, Adams NC, Seastrom GR. Transmission of measles in medical settings - United States, 1985-1989. Am J Med 1991;91(Suppl 3B):321S-4S.
19. Miranda AC, Falcào JM, Dias JA, Nóbrega SD, Rebelo MJ, Pimenta ZP, et al. Measles transmission in health facilities during outbreaks. Int J Epidemiol 1994;23:843-8.
20. Anderson RM, May RM. Immunisation and herd immunity. Lancet 1990;335:641-5.
21. Schlenker TL, Bain C, Baugham AL, Hadler SC. Measles herd immunity. The association of attack rates with immunization rates in preschool children. JAMA 1992;267:823-6.
22. Anderson RM, May RM. Age-related changes in the rate of disease transmission: implications for the design of vaccination programs. J Hyg Cambr 1985;94:385-436.
23. White CC, Koplan JP, Orenstein WA. Benefits, risks and costs of immunization for measles, mumps and rubella. Am J Public Health 1985;75:739-44.
24. Shepard DS. Economic analysis of investment priorities for measles control. J Infect Dis 1994;170(Suppl 1):S56-62.
25. Krause PJ, Gross PA, Barrett TL, Dellinger EP, Martone WJ, McGowan JE Jr, et al. Quality standard for assurance of measles immunity among health care workers. Clin Infect Dis 1994;18:431-6.
26. Subbarao EK, Amin S, Kuma ML. Prevaccination serologic screening for measles in health care workers. J Infect Dis 1991;163:876-8.
27. Sellick JA Jr, Longbine D, Schifeling R, Mylotte JM. Screening hospital employees for measles immunity is more cost effective than blind immunization. Ann Intern Med 1992; 116:982-4.
28. Ferson MJ, Robertson PW, Whybin LR. Cost effectiveness of prevaccination screening of health care works for immunity to measles, rubella and mumps. Med J Aust 1994;160: 478-82.